That's when The Wall Street Journal published an article questioning its -finger-prick technology for drawing blood for lab analysis. Among the more recent blows has been the assessment by the Centers of Medicare & Medicaid Services that some of its lab facilities need fixing. Until those changes are made, there could be immediate danger to the public.
Therefore, it's no surprise that, as Tess Townsend reports in Inc., Theranos has posted a help wanted for a storyteller. That applicant should have, indicates Townsend, "experience as junior copywriter/screenwriter in a creative environment." Some speculate that perhaps the folks at Theranos suspect there is a documentary or book being produced about its rise and fall. A storyteller could be part of the team to push back on that.
Theranos' troubles are happening at a time when the tech world is being shaken by plummeting stock prices. LinkedIn, for example, had a 40+ percent drop in one day last week. Venture capitalists are demanding results from startups or else - that is, they mandate liquidation so that they can get their funds back. And it's more difficult to scout up money for your good idea. Here is the analysis from BusinessInsider.
On Theranos' board is famous lawyer, David Boies. He represented hedge fund player Steven Cohen in his battle with the SEC. Cohen emerged from that okay. So, Boies could help guide Theranos, including its incoming writer, in reputation management. The court of public opinion, as every public relations agency knows, can be even more powerful than the court of law.